Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Nutrients|January 8, 2023
The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant ChemotherapyPaola Tiberio, Lidija Antunovic, Mariangela Gaudio, et al.La Radiologia Medica|December 1, 2025
[18F]FDG PET/CT as a biomarker for response evaluation in neoadjuvant treatment of early breast cancer: could it become a game-changer in the scenario of the emerging (de)-escalation strategies?Riccardo Gerosa, Fabrizia Gelardi, Paola Tiberio, et al.The Oncologist|May 14, 2025
Decoding NATALEE and MonarchE eligibility criteria in a real-world cohort of early breast cancer patientsJacopo Canzian, Damiano Gentile, Rita De Sanctis, et al.The Oncologist|May 20, 2024
Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizerRita De Sanctis, Paola Tiberio, Flavia Jacobs, et al.Cancers|January 23, 2024
The Impact of Different Patterns of Residual Disease on Long-Term Oncological Outcomes in Breast Cancer Patients Treated with Neo-Adjuvant ChemotherapyCorrado Tinterri, Bethania Fernandes, Alberto Zambelli, et al.Critical Reviews in Oncology/Hematology|March 10, 2024
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directionsRiccardo Gerosa, Rita De Sanctis, Flavia Jacobs, et al.Critical Reviews in Oncology/Hematology|March 9, 2025
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologistsMariangela Gaudio, Giulia Vatteroni, Rita De Sanctis, et al.The Oncologist|January 19, 2024
Ribociclib-Induced Cutaneous Adverse Events in Metastatic HR+/HER2- Breast Cancer: Incidence, Multidisciplinary Management, and Prognostic ImplicationRiccardo Giovanni Borroni, Michela Bartolini, Mariangela Gaudio, et al.Current Oncology (Toronto, Ont.)|June 25, 2026
Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch TrialsSilvia Belloni, Paola Tiberio, Emanuela Mencaglia, et al.Current Treatment Options in Oncology|March 13, 2024
Ovarian Suppression: Early Menopause and Late EffectsChiara Molinelli, Flavia Jacobs, Guilherme Nader-Marta, et al.Pageof 5